Pricing Log in Create free account

CervoMed Inc. (CRVO) vs NextCure, Inc. (NXTC)

CervoMed Inc. and NextCure, Inc. are both Biotechnology companies. CervoMed Inc. and NextCure, Inc. are of similar size ($23.4M and $21.9M). Across the 11 metrics below, CervoMed Inc. leads on 6 and NextCure, Inc. on 5.

Valuation

Metric CRVO NXTC Biotechnology median
P/E n/m n/m 10.60
P/S 3.61 1.03 9.40
P/B 0.63 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.62 0.39 9.02
Earnings yield (228.37%) (193.55%) (32.88%)
Free cash flow yield (196.71%) (133.11%) (23.13%)

Profitability

Metric CRVO NXTC Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (107.62%) (195.22%) (51.96%)
Return on assets (94.73%) (121.60%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRVO NXTC Biotechnology median
Revenue growth (TTM) (58.86%) — 6.76%
EPS growth (last fiscal year) (47.52%) 17.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO NXTC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.57 3.47 4.97
Net debt to EBITDA 0.74 0.75 1.01

Dividend

Metric CRVO NXTC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVO NXTC Biotechnology median
Market cap 21.93m 23.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack